Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial

Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major

(2017) Mehrnoush Kosaryan et al.   HEMOGLOBIN

Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

(2017) Sepideh Elyasi et al.   PHYTOTHERAPY RESEARCH

Effects of Silymarin on Diabetes Mellitus Complications: A Review

(2017) Aline Maria Stolf et al.   PHYTOTHERAPY RESEARCH

Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

(2016) Sepideh Elyasi et al.   PHYTOTHERAPY RESEARCH

Evaluating the Safety and Efficacy of Silymarin inβ-Thalassemia Patients: A Review

(2015) Behjat Al-Sadat Moayedi Esfahani et al.   HEMOGLOBIN

Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy

(2014) Sima Balouchi et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Silymarin's Protective Effects and Possible Mechanisms on Alcoholic Fatty Liver for Rats

(2013) Wei Zhang et al.   Biomolecules & Therapeutics

Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action

(2013) Anupom Borah et al.   CNS Neuroscience & Therapeutics

Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross-over trial

(2013) Kateřina Valentová et al.   FOOD AND CHEMICAL TOXICOLOGY

THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

(2013) Adel Abd elhaleim Hagag   Mediterranean Journal of Hematology and Infectious Diseases

A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine

(2012) Behjat Moayedi et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

(2012) Stephen J. Polyak et al.   HEPATOLOGY

Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, and Hemoglobin Levels Among Patients on Hemodialysis

(2011) Jamshid Roozbeh et al.   RENAL FAILURE

The iron-chelating potential of silybin in patients with hereditary haemochromatosis

(2010) C Hutchinson et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Milk thistle in liver diseases: past, present, future

(2010) Ludovico Abenavoli et al.   PHYTOTHERAPY RESEARCH

Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage

(2009) E. Shaker et al.   FOOD AND CHEMICAL TOXICOLOGY

Combined therapy of silymarin and desferrioxamine in patients with β-thalassemia major: a randomized double-blind clinical trial

(2009) Marjan Gharagozloo et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: A comparison with desferrioxamine

(2008) Marjan Gharagozloo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Silybin Treatment is Associated With Reduction in Serum Ferritin in Patients With Chronic Hepatitis C

(2008) Julie M. Bares et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY